Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors
Histone deacetylases (HDAC) are epigenetic enzymes responsible for repressing gene expression through the deacetylation of histone lysine residues. Therefore, inhibition of HDACs has become an interesting approach for the treatment of several diseases, including cancer, hematology, neurodegenerative...
Saved in:
Main Authors: | Beatriz Silva Urias (Author), Aline Renata Pavan (Author), Gabriela Ribeiro Albuquerque (Author), Igor Muccilo Prokopczyk (Author), Tânia Mara Ferreira Alves (Author), Thais Regina Ferreira de Melo (Author), Geraldo Rodrigues Sartori (Author), João Hermínio Martins da Silva (Author), Chung Man Chin (Author), Jean Leandro Dos Santos (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
by: Ehab Ghazy, et al.
Published: (2022) -
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs.
by: Hugo Rolando Vaca, et al.
Published: (2021) -
Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors
by: María Galán, et al.
Published: (2016) -
Investigating Potential Cancer Therapeutics: Insight into Histone Deacetylases (HDACs) Inhibitions
by: Basharat Ahmad, et al.
Published: (2024) -
Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs
by: Wang Y, et al.
Published: (2017)